Ortho Clinical Diagnostics markets column agglutination technology (CAT) worldwide. This is due to the many benefits of this technology over standard methods. The ORTHO BioVue system brand has had a proven track record for more than 10 years in over 20 countries.
The ORTHO BioVue system column agglutination technology standardizes blood typing and compatibility testing in a 6-microcolumn cassette preloaded with diluent and/or reagent and glass beads. Test red cells, with or without serum, are placed in the chamber above the column. Upon centrifugation, red cells are forced through the bead column where agglutinated cells are trapped, while unagglutinated red cells travel to the bottom of the column, forming a discrete pellet.
ORTHO BioVue offers many advantages over traditional methods:
• Improved sensitivity
• Standardized procedures
• Objectivity
• Increased productivity and ease of use
• Easy to automate
BioVue cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack. In addition a full automation platform, the ORTHO AutoVue System is available for larger volume testing.